Researchers Identify TRAM Role in Myddosome Assembly
A 2026 study finds the TRAM protein is essential for the maturation and release of cytosolic myddosomes in mouse macrophages.
Updated on Oct. 27, 2026 in Life Sciences
Researchers have discovered that the TRAM protein, encoded by the Ticam2 gene, plays a critical regulatory role in the assembly of myddosomes. Published in 2026, the study reveals that TRAM deficiency impairs the maturation and release of these signaling complexes from Toll-like receptor sites.
Why it matters
Understanding how proto-myddosomes transition into mature, cytosolic signaling complexes is vital for decoding immune system activation. The identification of TRAM as a gatekeeper explains how cells regulate the secondary response genes necessary for an effective immune defense.
A genome-wide CRISPR screen of mouse macrophages identified that Ticam2 mutants fail to dissociate MyD88 from receptors. Co-immunoprecipitation confirmed that MyD88-TRAM complexes are required for the transition from proto-myddosome to the mature cytoplasmic form.
The players
Nature
This is a prominent international weekly journal of science that publishes peer-reviewed research across a wide range of academic disciplines.
The details
Proto-myddosomes initially cluster at Toll-like receptor sites but require TRAM to successfully transition into the cytoplasm. Without this protein, cells exhibit an impaired expression of secondary response genes, fundamentally altering their inflammatory response.
Timeline
The findings regarding TRAM-dependent myddosome assembly were published in Nature in 2026.
The Big Picture
This study updates the mechanical model of the Toll-like receptor signaling pathway by identifying the regulatory role of TRAM in the cytoplasmic release of myddosomes. By proving that myddosome maturation occurs in the cytoplasm rather than at the receptor, the research resolves a long-standing question regarding how these signaling complexes are dispatched.
This breakthrough improves our fundamental understanding of how immune cells coordinate their inflammatory responses. These insights could eventually lead to new therapeutic targets for managing diseases driven by chronic or dysregulated immune signaling.
The takeaway
This study highlights the precision of intracellular signaling, where a single protein determines the success of a major immune response. Scientists and researchers can use these findings to further investigate how complex biological signals are partitioned within the cell.
Further reading
Learn more about the latest research in the field at Life Sciences.
More information
Read the original Nature Immunology study on myddosomes for comprehensive data and methodology.
Source note: This article includes information reported by Nature.
